title: Bivalent HPV Recombinant Vaccine (Cervarix) for the Prevention of Cervical Cancer.
authors.affiliation: University of Missouri-Kansas City School of Pharmacy, Kansas City, MO, USA. stephanie.schauner@hcamidwest.com
authors.forename: Stephanie
authors.initials: S
authors.lastname: Schauner
authors.forename: Corey
authors.initials: C
authors.lastname: Lyon
mesh_terms: D052685:Alphapapillomavirus; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D030361:Papillomavirus Infections / Q000150:complications* / Q000517:prevention & control; D053918:Papillomavirus Vaccines / Q000008:administration & dosage*; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control* / Q000821:virology
chemical_list: D053918:Papillomavirus Vaccines; C510352:human papillomavirus vaccine, L1 type 16, 18